NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ:

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
413
NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in cannabinoid drug research, development and significant manufacturing know-how,” said Eric A. Adams, InMed president and CEO. “Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed was able to advance its programs and achieve a number of key milestones. As we move forward into 2023, we are very encouraged by the strength of our pharmaceutical programs, with several material milestones anticipated in the coming quarters.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

InMed Pharmaceuticals, Inc. (INM) Stock Research Links

INM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEC Firms Revamp Strategies Amid Talent Tug-of-War

Updated Category News Views 3

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 3

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Curaleaf Eyes Growth: Conference Signals Opportunities

Updated Category News Views 0

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 3

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 3

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Guardio's AI-Driven Cybersecurity Triumphs at $1.1B Value

Updated Category News Views 0

A New Chapter in Cybersecurity's Playbook Guardio just hit a milestone that'll make any well-seasoned investor sit up and take notice. Their recent $1.1 billion valuation, fueled by a fresh $40 million funding round, underscores a seismic shift in the consumer cybersecurity landscape. We're talking a lineup of some seriously smart money like Assaf Rappaport, co-founder of...

Continue Reading
TVEyes Archive+: Revolutionizing Media Intelligence

Updated Category News Views 3

TVEyes Archive+ Takes Media Intelligence to New Heights Dishing out another update here, folks. TVEyes, the media intelligence powerhouse, just kicked off something that's got the potential to change the strategic media game—they call it Archive+. This tool isn’t just plundering old tapes; we're talking nearly two damn decades worth of historical broadcasts and...

Continue Reading
Pulnovo's PADN System Revolutionizes PH-LHD Treatment

Updated Category News Views 0

Pulnovo's Breakthrough in Heart Disease Management When Pulnovo Medical rolled out the PADN-HF-PH trial results at the ESC Congress 2026, seasoned investors like me sat up and took note. The trial, hot off the presses in The New England Journal of Medicine, unveiled how Pulmonary Artery Denervation (PADN) is throwing a wrench into the gears of conventional treatment of...

Continue Reading
MemoryDriver Relaunches with Navigation Challenge

Updated Category News Views 2

MemoryDriver's Relight: A Blazing New Course in Brain Health Look at this: Evon Medics is back with a bang, and they're handing us more than just another mind-numbing app update. On September 15, they're flipping the switch on MemoryDriver, their revamped brain-training gig, with a national 'Beat the Clock' Challenge. It’s up for grabs, totally free, and full of...

Continue Reading
Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 3

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading

Top 5 Most Recently Viewed Articles

Adverum Biotechnologies Awards Stock Options to New Hire

Updated Category News Views 170

Adverum Biotechnologies Makes Inducement Grants Adverum Biotechnologies, Inc. (NASDAQ: ADVM) has made headlines recently by announcing the grant of stock options to a new member of their team. This strategic move is part of Adverum’s 2017 Inducement Plan, which is designed to attract and retain top talent by providing equity opportunities that align the interests of...

Continue Reading
Vanguard's February 2025 ETF Cash Distributions Explained

Updated Category News Views 304

Vanguard's February 2025 ETF Cash Distributions Vanguard Investments Canada Inc. has announced important cash distributions for various Vanguard ETFs. According to the latest update, unitholders of record on March 3, 2025, will receive distributions on March 10, 2025. Understanding these distributions is vital for investors, as they can influence investment decisions and...

Continue Reading
JetBlue Offers Special Nonstop Flights to the Big Game in New Orleans

Updated Category News Views 315

JetBlue Announces Special Nonstop Flights for Sports Fans JetBlue (NASDAQ: JBLU) is excited to provide sports enthusiasts with an exceptional travel experience this game season. By launching limited-time nonstop flights from major hubs like Newark and New York’s JFK Airport to the vibrant city of New Orleans, JetBlue aims to accommodate hundreds of additional fans eager...

Continue Reading
Examining Super Micro's Challenges Amid Regulatory Scrutiny

Updated Category News Views 194

Super Micro Computer Inc. came under fire in 2024 when the US Justice Department launched an investigation into allegations made by a former employee. This probe isn't just a minor hiccup; it follows closely on the heels of Super Micro settling with the SEC for $17.5 million over prior accounting issues back in 2020. Traders weren't just watching from the sidelines—they...

Continue Reading
ONEOK's Commitment to Dividends Shows Strong Financial Stability

Updated Category News Views 151

ONEOK Declares Consistent Quarterly Dividend The board of directors at ONEOK, Inc. (NYSE: OKE) announced a quarterly dividend of $1.03 per share. This declaration remains unchanged from the previous quarter, leading to an annualized amount of $4.12 per share. This consistency highlights ONEOK's reliability and commitment to its shareholders. Dividend Payment Schedule...

Continue Reading